Aerovate Therapeutics Inc.
AVTE
|
|
| |
|
| Trading Volume | 15,402 |
|
|
30.72 - 1.41 |
| Market Cap Full | $ 50.9M |
Quarterly +
| 2026 | 2025 | 2024 | 2023 | |
|---|---|---|---|---|
| Q1 | - | 1.1% | 32.3% | -31.2% |
| Q2 | - | - | -94.6% | -15% |
| Q3 | - | - | 1.7% | -20.9% |
| Q4 | - | - | 2.7% | 70.4% |
Monthly +
| J | F | M | A | M | J | J | A | S | O | N | D |
| 2026 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | - | - | - | - |
| 2025 | |||||||||||
| 1.1 | - | - | - | - | - | - | - | - | - | - | - |
| 2024 | |||||||||||
| -14.7 | 19.5 | 29.7 | -27 | -20 | -90.5 | 8.4 | 1.7 | - | - | - | - |
| 2023 | |||||||||||
| -22 | 7.5 | -17.9 | 4 | -22.5 | 5.5 | 1.8 | -8.9 | -14.6 | -21.8 | 48.1 | 44.1 |
| 2022 | |||||||||||
| -8.6 | -9.3 | 87.4 | -30.4 | -0.9 | 23.8 | 42.4 | -10.9 | -16.4 | 17.7 | -3.4 | 55.5 |
| 2021 | |||||||||||
| - | - | - | - | - | - | -42.4 | 29.9 | 22.8 | -24.1 | -15.3 | -12.6 |
EPS
| 2023 | 2022 | 2021 | |
|---|---|---|---|
| Q1 | -0.7 | -0.5 | -11.5 |
| Q2 | -0.8 | -0.5 | -23.8 |
| Q3 | -0.7 | -0.6 | -0.3 |
| Q4 | 0 | -0.6 | 33.7 |
| A | -2.14 | -2.1 | -1.9 |